Klaria Pharma Holding Investor Relations Material

Klaria Pharma Holding AB is a Swedish biotechnology and medical research company focused on developing and commercializing therapeutic drugs. The company's core technology involves a patented drug delivery platform using an alginate-based polymer film that facilitates rapid and reliable transmucosal absorption. This innovative method allows the medication to be distributed directly into the bloodstream via a mucoadhesive film, offering benefits such as shorter time to effect, increased control, and simple handling. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq Stockholm.